Evidence map›Paper›PMID 36333391›Full record

ArticleScientific reports2022

Significantly increased risk of chronic obstructive pulmonary disease amongst adults with predominantly mild congenital heart disease.

Dominic J F Byrne, Simon G Williams, Apostol Nakev, Simon Frain, Stephanie L Baross, Jørgen Vestbo, Bernard D Keavney, David Talavera

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Dominic J F ByrneDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK.
Simon G WilliamsDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK.
Apostol NakevDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK.
Simon FrainDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK.
Stephanie L BarossDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK.
Jørgen VestboDivision of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, The University of Manchester, Oxford Road, Manchester, UK.
Bernard D KeavneyDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK.
David TalaveraDivision of Cardiovascular Sciences, School of Medical Sciences, The University of Manchester, Oxford Road, Manchester, UK. david.talavera@manchester.ac.uk.
University of Manchester · GB

Funding

British Heart Foundation CH/13/2/30154British Heart Foundation RG/15/12/31616British Heart Foundation RG/F/21/110050Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/R010900/1
6 · The paper itself

Abstract

Adults with congenital heart disease (CHD) face increased risk of various comorbid diseases. Previous work on lung dysfunction in this population has mainly focused on restrictive lung disease, in patients with severe CHD phenotypes. We examined the association of mild CHD with chronic obstructive pulmonary disease (COPD) in the UK Biobank (UKB). Electronic health records (EHR) were used to identify 3385 CHD cases and 479,765 healthy controls in UKB, before performing a case-control analysis over a 20-year study period for a total of > 9.5 M person-years of follow-up. Our analysis showed that UKB participants with CHD are at substantially greater risk of developing COPD than healthy controls (8.7% vs 3.1% prevalence, unadjusted OR 2.98, 95% CI 2.63, 3.36, P = 1.40e-53). Slightly increased rates of smoking were observed amongst CHD cases, however the association with COPD was shown to be robust to adjustment for smoking and other factors known to modulate COPD risk within a multivariable-adjusted Cox regression framework (fully adjusted HR 2.21, 95% CI 1.97, 2.48, P = 5.5e-41). Care for adults with CHD should aim to mitigate their increased risk of COPD, possibly via increased smoking cessation support.

Indexed as

Heart Defects, CongenitalPulmonary Disease, Chronic ObstructiveSmoking CessationHumansRisk FactorsSmoking

Identifiers

PMID36333391
PMCPMC9636374
OpenAlexW4308194666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.